RIP kinase inhibitor RIPK1-IN-7, Purity ≥98%

Cat. No.: X23-10-ZQ171

RIP kinase inhibitor RIPK1-IN-7, Purity ≥98%

Synonym: 2300982-44-7; RIPK1-IN-7; 1-(5-(4-Amino-7-ethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethoxy)phenyl)ethan-1-one; RIP kinase inhibitor

  • CAS Number: 2300982-44-7
  • Compound CID: 137321158
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RIPK1-IN-7 is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
481.47
Molecular Formula
C25H22F3N5O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
RIPK1-IN-7 can be studied for its role in blocking RIPK1 activity and modulating necroptotic pathways.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.